Ombeva Malande is a Vaccinologist & Paediatric Infectious Diseases Sub-Specialist, and Director of the East Africa Centre for Vaccines and Immunization (ECAVI) – a vaccines systems support, research, advocacy and training program in Eastern Africa.
Dr Malande is a certified fellow of the College of Paediatricians of South Africa (infectious diseases subspecialty). He received his MPhil in Paediatric Infectious Diseases & Vaccinology from the University of Cape Town & Red Cross Children’s Hospital in South Africa. He holds a Masters of Medicine in Paediatrics & Child Health from Makerere University (Uganda), and an MB ChB from Moi University (Kenya). He is a sub-specialist consultant Paediatrician and Lecturer of Paediatrics & Child Health, Egerton University, Kenya, and an Honorary Lecturer at Makerere University.
Dr Malande is a member of the Kenya Paediatric Association (KPA) National Executive Committee and a member of the KPA Committee on Child Health Policy & Advocacy. He is a weekly columnist and advocate of child health with the Eve magazine of the Saturday Standard Newspaper in Kenya. He helped set up two non-profit community health clinics with the Manu Chandaria Foundation in Kampala (2007) and in Tororo (2012), Uganda.
He has published and reviewed for various scientific journals on immunology, vaccinology, infectious diseases, child health and paediatrics.
Dr Malande was included in the Marquis Who’s Who In The World® 2016 (33rd edition), in recognition of his work. He was recently accorded the Cambridge Award for Outstanding Achievement in Medicine (2016). He was successfully selected for inclusion in the newest reference directory of both the International Biographic Centre’s Great Men and Women of Science, 2017 (1st edition) and in the upcoming 2,000 Outstanding Intellectuals of the 21st Century (10th edition).
Immunology; Vaccinology; Infectious diseases; Child health; Paediatrics; Antibiotic stewardship; Emerging resistance patterns; Clinical presentation and outcomes for extended spectrum beta-lactamase (ESBL) producing- and carbapenem-resistant enterobacteriaceae (CRE) in the African paediatric setting.